Genetic Immunization of Wild-Type and Hepatitis C Virus Transgenic Mice Reveals a Hierarchy of Cellular Immune Response and Tolerance Induction against Hepatitis C Virus Structural Proteins
Jujin Satoi(National Institutes of Health), T. Jake Liang(National Institutes of Health), Barbara Rehermann(United States Department of Health and Human Services), Kazumoto Murata(National Center for Global Health and Medicine), Heiner Wedemeyer(Medizinische Hochschule Hannover), Martin Lechmann(Roche (Switzerland)), Elanchezhiyan Manickan(University of Madras), Zhensheng Zhang(National Institutes of Health)
Cited by 32
Related Papers
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
|Nature Genetics|2013|922
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
|New England Journal of Medicine|2014|877
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817